This outcome was verified after controlling for established demographic, clinical and laboratory factors and biomarkers of HF survival, including N-terminal pro b-type natriuretic peptide, HSP, MPO, CRP, creatinine, history of diabetes and more, in all three groups of patients. This evidence concerns the gene HSP90B2P and diabetes mellitus.